Cannabis and Brain: Disrupting Neural Circuits of Memory
DOI:
https://doi.org/10.6000/2292-2598.2018.06.02.4Keywords:
Cannabis, Cannabinoids, Marijuana, Brain, Neural Circuits, Memory.Abstract
Cannabis is a federally controlled substance, it’s very familiar to many but its neurobiological substrates are not well-characterized. In the brain, most areas prevalently having cannabinoid receptors have been associated with behavioral control and cognitive effects due to cannabinoids. Study over the last several decades suggested cannabinoids (CBs) exert copious oftentimes opposite effects on countless neuronal receptors and processes. In fact, owing to this plethora of effects, it’s still cryptic how CBs trigger neuronal circuits. Cannabis use has been revealed to cause cognitive deficits from basic motor coordination to more complex executive functions, for example, the aptitude to plan, organize, make choices, solve glitches, remember, and control emotions as well as behavior. Numerous factors like age of onset and duration of cannabis use regulate the severity of the difficulties. People with the cannabis-linked deficiency in executive functions have been found to have trouble learning and applying the skills requisite for fruitful recovery, setting them at amplified risk for deterioration to cannabis use. Exploring the impacts of cannabis on the brain is imperative. Therefore the intention of this study was to analyze the neuropsychological effects and the impact of CBs on the dynamics of neural circuits, and its potential as the drug of addiction.
References
Vij K. Textbook of forensic medicine & toxicology: Principles & practice. 6th ed., India: Elsevier; 2014.
Russo EB. Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. 1st ed., The Haworth Integrative Healing Press; Binghamton-USA, 2013; PP 429; 0-7890-1507-2
Newton DE. World energy crisis: a reference handbook, 1st ed.; ABC-CLIO; Santa Barbara-USA,2013. DOI: https://doi.org/10.5040/9798216038924
Benbadis SR, Sanchez-Ramos J, Bozorg A, Giarratano M, Kalidas K, Katzin L, et al. Medical marijuana in neurology. Expert Rev Neurother 2014; 14(12): 1453-65. https://doi.org/10.1586/14737175.2014.985209 DOI: https://doi.org/10.1586/14737175.2014.985209
United Nations Office on Drugs and Crime. World drug report 2015. In: Nations U, editor. New York, 2015.
Anthony S, Fred B, Jennifer D, Sarah D. Marijuana use and support for legal marijuana continue to climb. [cited 2018 February 12]: Available from: https://www.cbsnews.com/ news/marijuana-use-and-support-for-legal-marijuana-continue-to-climb/
Mack J. Marijuana use, legal and illegal, is increasing in Michigan. [cited 2018 February 12]: Available from: http://www.mlive.com/news/index.ssf/2017/07/marijuana_use_legal_and_illega.html
Murnion B. Medicinal cannabis. Aust presc 2015; 38(6): 212-15. https://doi.org/10.18773/austprescr.2015.072 DOI: https://doi.org/10.18773/austprescr.2015.072
Anonymous. Release the strains. Nat Med 2015; 21(9): 963. https://doi.org/10.1038/nm.3946 DOI: https://doi.org/10.1038/nm.3946
Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. The J of Hum Pharm and Drg Ther 2013; 33(2): 195-209. https://doi.org/10.1002/phar.1187
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 2015, 33(2): 195-209. https://doi.org/10.1001/jama.2015.6358 DOI: https://doi.org/10.1001/jama.2015.6358
Jensen B, Chen J, Furnish T, Wallace M. Medical marijuana and chronic pain: A review of basic science and clinical evidence. Curr pai and Hea Reps 2015: 19(10): 50. DOI: https://doi.org/10.1007/s11916-015-0524-x
Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001; 178(2): 116-22. https://doi.org/10.1192/bjp.178.2.116
Riviello RJ. Manual of forensic emergency medicine: A guide for clinicians, 1st ed., Jones & Bartlett Publishers, 2009; 295.
Crippa JA, Zuardi AW, Martín‐Santos R, Bhattacharyya S, Atakan Z, McGuire et al. Cannabis and anxiety: A critical review of the evidence. Hum Psychopharm: Clin and Exp 2009; 24(7): 515-23. https://doi.org/10.1002/hup.1048 DOI: https://doi.org/10.1002/hup.1048
Leweke FM, Mueller JK, Lange B, Rohleder C. Therapeutic potential of cannabinoids in psychosis. Bio Psy 2016; 79(7): 604-12. https://doi.org/10.1016/j.biopsych.2015.11.018 DOI: https://doi.org/10.1016/j.biopsych.2015.11.018
Ksir C, Hart CL. Cannabis and psychosis: A critical overview of the relationship. Curr psy rep 2016; 18(2): 12. https://doi.org/10.1007/s11920-015-0657-y DOI: https://doi.org/10.1007/s11920-015-0657-y
Gettman J, Kennedy M. Let it grow—the open market solution to marijuana control. Harm Reduct J 2014; 11(1): 32. https://doi.org/10.1186/1477-7517-11-32 DOI: https://doi.org/10.1186/1477-7517-11-32
United Nations Office on Drugs and Crime. World Drug Report 2010. New York: United Nations Publication, 2010.
Gordon AJ, Conley JW, Gordon JM. Medical consequences of marijuana use: a review of current literature. Curr Psy Rep 2013; 15(12): 419. https://doi.org/10.1007/s11920-013-0419-7 DOI: https://doi.org/10.1007/s11920-013-0419-7
American College of Obstetricians and Gynecologists. Marijuana use during pregnancy and lactation. Committee Opinion. Obs and Gyn 2015; 126(1): 234-8. DOI: https://doi.org/10.1097/01.AOG.0000467192.89321.a6
Gunn JK, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: A systematic review and meta-analysis. BMJ Open 2016; 6(4): e009986. https://doi.org/10.1136/bmjopen-2015-009986 DOI: https://doi.org/10.1136/bmjopen-2015-009986
Conner SN, Bedell V, Lipsey K, Macones GA, Cahill AG, Tuuli MG. Maternal marijuana use and adverse neonatal outcomes. Obs & Gyn 2016; 128(4): 713-23. https://doi.org/10.1097/AOG.0000000000001649 DOI: https://doi.org/10.1097/AOG.0000000000001649
Subbaraman MS. Can cannabis be considered a substitute medication for alcohol? Alco and Alcoh 2014; 49(3): 292-8. https://doi.org/10.1093/alcalc/agt182 DOI: https://doi.org/10.1093/alcalc/agt182
Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. J of Med Tox 2017; 13(1): 71-87. https://doi.org/10.1007/s13181-016-0595-z DOI: https://doi.org/10.1007/s13181-016-0595-z
Uddin MS, Amran MS. Cannabinoid hyperemesis: An erratic syndrome linked with Cannabis abuse. J Psychiatry 2018; 21(2): 1-2. https://doi.org/10.4172/2378-5756.1000e116 DOI: https://doi.org/10.4172/2378-5756.1000e116
Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 1995; 48: 443-450.
Pinterest.com. CB1 receptors in brain. [cited 2018 February 12]: https://www.pinterest.com.mx/pin/359443613992533228
Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 2008; 153: 199-215. https://doi.org/10.1038/sj.bjp.0707442 DOI: https://doi.org/10.1038/sj.bjp.0707442
Iversen L. Cannabis and the brain. Br 2003; 126: 1252-1270. https://doi.org/10.1093/brain/awg143 DOI: https://doi.org/10.1093/brain/awg143
Limebeer CL, Rock EM, Mechoulam R, Parker LA. The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex. Br J Pharmacol 2012; 167: 1126-1136. https://doi.org/10.1111/j.1476-5381.2012.02066.x DOI: https://doi.org/10.1111/j.1476-5381.2012.02066.x
Scholastic. The Science of Marijuana: How THC Affects the Brain. [cited 2018 February 12]: Available from: http://headsup.scholastic.com/students/the-science-of-marijuana
Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997; 74(2):129-80. https://doi.org/10.1016/S0163-7258(97)82001-3 DOI: https://doi.org/10.1016/S0163-7258(97)82001-3
Benson Jr JA, Watson Jr SJ, Joy JE. Marijuana and medicine; The National Academies Press: Washington DC, USA, 1999; 288.
Eubanks LM, Rogers CJ, Beuscher IV AE, Koob GF, Olson AJ, Dickerson TJ, et al. A molecular link between the active component of marijuana and Alzheimer's disease pathology. Mol Pharm 2006; 3(6): 773-7. https://doi.org/10.1021/mp060066m DOI: https://doi.org/10.1021/mp060066m
Reggio PH. Endocannabinoid binding to the cannabinoid receptors: What is known and what remains unknown. Curr Med Chem 2010; 17(14): 1468-1486. https://doi.org/10.2174/092986710790980005 DOI: https://doi.org/10.2174/092986710790980005
Sherman C, Writer NN. The defining features of drug intoxication and addiction can be traced to disruptions in cell-to-cell signaling. NIDA Notes: NIH, NIDA 2007; 21(4).
Osborne GB, Fogel C. Understanding the motivations for recreational marijuana use among adult Canadians. Subst Use Misuse 2008; 43(3-4): 539-72. https://doi.org/10.1080/10826080701884911 DOI: https://doi.org/10.1080/10826080701884911
Shrivastava A, Johnston M, Terpstra K, Bureau Y. Pathways to psychosis in Cannabis abuse. Clin Schizophr Relat Psychoses 2013; 9(1): 30-5. https://doi.org/10.3371/CSRP.SHJO.030813 DOI: https://doi.org/10.3371/CSRP.SHJO.030813
Niesink RJ, van Laar MW. Does cannabidiol protect against adverse psychological effects of THC? Front Psychiatry 2013, 4: 130. https://doi.org/10.3389/fpsyt.2013.00130 DOI: https://doi.org/10.3389/fpsyt.2013.00130
Shufman E, Lerner A, Witztum E. Depersonalization after withdrawal from cannabis usage. Euro PMC 2005, 144(4): 249.
Johnson BA. Psychopharmacological effects of cannabis. Br J Hosp Med 1990; 43(2): 114-6.
Barceloux DG. Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants. John Wiley & Sons: New York; 2012. https://doi.org/10.1002/9781118105955 DOI: https://doi.org/10.1002/9781118105955
Atakan Z. Cannabis, a complex plant: Different compounds and different effects on individuals. Ther Adv Psychopharmacol 2012; 2(6): 241-54. https://doi.org/10.1177/2045125312457586 DOI: https://doi.org/10.1177/2045125312457586
Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007; 9(4):413. DOI: https://doi.org/10.31887/DCNS.2007.9.4/nkogan
Grotenhermen F, Müller-Vahl K. The Therapeutic Potential of Cannabis and Cannabinoids. Dtsch Arztebl Int 2012; 109(29-30): 495-501. https://doi.org/10.3238/arztebl.2012.0495
Hill KP. Medical Marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA 2015; 313(24): 2474-83. https://doi.org/10.1001/jama.2015.6199 DOI: https://doi.org/10.1001/jama.2015.6199
Thompson AE. Medical Marijuana. JAMA 2015; 313(24): 2508. https://doi.org/10.1001/jama.2015.6676 DOI: https://doi.org/10.1001/jama.2015.6676
Grotenhermen F, Müller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 2012; 109(29-30): 495. https://doi.org/10.3238/arztebl.2012.0495 DOI: https://doi.org/10.3238/arztebl.2012.0495
American Academy of Neurology. Medical marijuana in certain neurological disorders. [cited 2018 February 12]: Available from: https://www.aan.com/Guidelines/Home/ GetGuidelineContent/650
Dornbush RL, Freedman AM, Fink M. Chronic cannabis use. Ann N Y Acad Sci 1976; 282: 1-430. DOI: https://doi.org/10.1111/j.1749-6632.1976.tb49877.x
Filbey FM, Aslan S, Calhoun VD, Spence JS, Damaraju E, Caprihan A, Segall J. Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A. 2014 Nov 25; 111(47): 16913-8. https://doi.org/10.1073/pnas.1415297111 DOI: https://doi.org/10.1073/pnas.1415297111
Solowij N. Cannabis and cognitive functioning. Cambridge: Cambridge University Press; 1998; 92-102. https://doi.org/10.1017/CBO9780511526824 DOI: https://doi.org/10.1017/CBO9780511526824
Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001; 58(10): 909-15. https://doi.org/10.1001/archpsyc.58.10.909 DOI: https://doi.org/10.1001/archpsyc.58.10.909
Hollister LE. Health aspects of cannabis. Pharmacol Rev 1986; 38: 1–20.
Block RI, O’Leary DS, Ehrhardt JC, Jean CA, Ghoneim MM, Stephan A, et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000; 11: 491-6. https://doi.org/10.1097/00001756-200002280-00013 DOI: https://doi.org/10.1097/00001756-200002280-00013
Scallet AC, Uemura E, Andrews A, Ali SF, Mcmillan DE, Paule et al. Morphometric studies of the rat hippocampus following chronic delta‐9‐tetrahydrocannabinol (THC). Brain Res 1987; 436: 193-8. https://doi.org/10.1016/0006-8993(87)91576-9 DOI: https://doi.org/10.1016/0006-8993(87)91576-9
Landfield PW, Cadwallader LB, Vinsant S. Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res 1988; 443: 47-62. https://doi.org/10.1016/0006-8993(88)91597-1 DOI: https://doi.org/10.1016/0006-8993(88)91597-1
Chan PC, Sills RC, Braun AG, Haseman K, Bucher JR. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fundam Appl Toxicol 1996; 30: 109-17. https://doi.org/10.1006/faat.1996.0048 DOI: https://doi.org/10.1093/toxsci/30.1.109
Harper JW, Heath RG, Myers WA. Effects of cannabis sativa on ultrastructure of the synapse in monkey brain. J Neurosci Res 1977; 3: 87-93. https://doi.org/10.1002/jnr.490030202 DOI: https://doi.org/10.1002/jnr.490030202
Heath RG, Fitzjarrell AT, Fontana CJ, Garey RE. Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. Biol Psychiatry 1980; 15: 657-90.
Scallet AC. Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals. Pharmacol Biochem Behav 1991; 40: 671-6. https://doi.org/10.1016/0091-3057(91)90380-K DOI: https://doi.org/10.1016/0091-3057(91)90380-K
Downer E, Boland B, Fogarty M, Campbell V. Delta 9‐tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor. Neuroreport 2001; 12: 3973-8. https://doi.org/10.1097/00001756-200112210-00024 DOI: https://doi.org/10.1097/00001756-200112210-00024
Chan GC, Hinds TR, Impey S, Storm DR. Hippocampal neurotoxicity of delta 9-tetrahydrocannabinol. J Neurosci 1998; 18: 5322-32. https://doi.org/10.1523/JNEUROSCI.18-14-05322.1998 DOI: https://doi.org/10.1523/JNEUROSCI.18-14-05322.1998
Sánchez C, Galve-Roperh I, Canova C, Brachet P, Guzmán M. Delta 9‐tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 1998; 436: 6-10. https://doi.org/10.1016/S0014-5793(98)01085-0 DOI: https://doi.org/10.1016/S0014-5793(98)01085-0
Galve-Roperh I, Sánchez C, Cortés ML, del Pulgar TG, Izquierdo M, Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal‐regulated kinase activation. Nat Med 2000; 6: 313-9. https://doi.org/10.1038/73171 DOI: https://doi.org/10.1038/73171
Guzmán M, Sánchez C, Galve‐Roperh I. Control of the cell survival/death decision by cannabinoids. J Mol Med 2001; 78: 613-25. https://doi.org/10.1007/s001090000177 DOI: https://doi.org/10.1007/s001090000177
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 1999; 19: 2987-95. https://doi.org/10.1523/JNEUROSCI.19-08-02987.1999 DOI: https://doi.org/10.1523/JNEUROSCI.19-08-02987.1999
Panikashvili D, Simeonidou C, Ben-Shabat S, Hanuš L, Breuer A. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001; 413: 527-31. https://doi.org/10.1038/35097089 DOI: https://doi.org/10.1038/35097089
Van der Stelt M, Veldhuis WB, Bär PR, Veldink GA, Vliegenthart JF, Nicolay K. Neuroprotection by delta-9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain‐induced in vivo excitotoxicity. J Neurosci 2001; 21: 6475-9. https://doi.org/10.1523/JNEUROSCI.21-17-06475.2001 DOI: https://doi.org/10.1523/JNEUROSCI.21-17-06475.2001
Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 1998; 54: 459-62. https://doi.org/10.1124/mol.54.3.459 DOI: https://doi.org/10.1124/mol.54.3.459
Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 2000; 278: 157-60. https://doi.org/10.1016/S0304-3940(99)00922-2 DOI: https://doi.org/10.1016/S0304-3940(99)00922-2
Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (‐)delta 9‐tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 1998; 95: 8268-73. https://doi.org/10.1073/pnas.95.14.8268 DOI: https://doi.org/10.1073/pnas.95.14.8268
Calabria B, Degenhardt L, Hall W, Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010; 29(3): 318-30. https://doi.org/10.1111/j.1465-3362.2009.00149.x DOI: https://doi.org/10.1111/j.1465-3362.2009.00149.x
Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178(2): 101-6. https://doi.org/10.1192/bjp.178.2.101 DOI: https://doi.org/10.1192/bjp.178.2.101
Fitzgerald KT, Bronstein AC, Newquist KL. Marijuana poisoning. Top Companion Anim Med 2013; 28(1): 8-12. https://doi.org/10.1053/j.tcam.2013.03.004 DOI: https://doi.org/10.1053/j.tcam.2013.03.004
O'Neil, Maryadele J. The Merck index : an encyclopedia of chemicals, drugs, and biologicals. 12th ed., New Jersey. Cambridge, UK : Royal Society of Chemistry; 2013, 234.
Erowid. Cannabis: Legal Status. [cited 2018 February 12]: Available from: https://erowid.org/plants/cannabis/cannabis_ law.shtml
Mikuriya TH. Historical aspects of cannabis sativa in western medicine. New Physician. 1969; 18: 902-8.
Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 2011; 5(1): 1-8. https://doi.org/10.1097/ADM.0b013e31820c23fa DOI: https://doi.org/10.1097/ADM.0b013e31820c23fa
Sandler RA, Fetterhoff D, Hampson RE, Deadwyler SA, Marmarelis VZ. Cannabinoids disrupt memory encoding by functionally isolating hippocampal CA1 from CA3. PLoS Comput Biol 2017; 13(7): e1005624. https://doi.org/10.1371/journal.pcbi.1005624 DOI: https://doi.org/10.1371/journal.pcbi.1005624
Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001; 178: 116-22. https://doi.org/10.1192/bjp.178.2.116 DOI: https://doi.org/10.1192/bjp.178.2.116
Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 1997; 56: 803-7. https://doi.org/10.1016/S0091-3057(96)00426-1 DOI: https://doi.org/10.1016/S0091-3057(96)00426-1
Andréasson S, Engström A, Allebeck P, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-5. https://doi.org/10.1016/S0140-6736(87)92620-1 DOI: https://doi.org/10.1016/S0140-6736(87)92620-1
Mathers DC, Ghodse AH. Cannabis and psychotic illness. Br J Psychiatry 1992; 161: 648-53. https://doi.org/10.1192/bjp.161.5.648 DOI: https://doi.org/10.1192/bjp.161.5.648
Hambrecht M, Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust NZ J Psychiatry 2000; 34: 468-75. https://doi.org/10.1080/j.1440-1614.2000.00736.x DOI: https://doi.org/10.1046/j.1440-1614.2000.00736.x
Williams JH, Wellman NA, Rawlins JNP. Cannabis use correlates with schizotypy in healthy people. Addiction 1996; 91: 869-77. https://doi.org/10.1111/j.1360-0443.1996.tb03581.x DOI: https://doi.org/10.1046/j.1360-0443.1996.91686912.x
Skosnik PD, Spatz‐Glenn L, Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 2001; 48: 83-92. https://doi.org/10.1016/S0920-9964(00)00132-8 DOI: https://doi.org/10.1016/S0920-9964(00)00132-8
Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. Acta Psychiatr Scand 1989; 79: 505-10. https://doi.org/10.1111/j.1600-0447.1989.tb10296.x DOI: https://doi.org/10.1111/j.1600-0447.1989.tb10296.x
Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199. https://doi.org/10.1136/bmj.325.7374.1199 DOI: https://doi.org/10.1136/bmj.325.7374.1199
Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-3. https://doi.org/10.1136/bmj.325.7374.1212 DOI: https://doi.org/10.1136/bmj.325.7374.1212
Fergusson DM, Horwood LJ, Swain‐Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21. https://doi.org/10.1017/S0033291702006402 DOI: https://doi.org/10.1017/S0033291702006402
Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195-8. https://doi.org/10.1136/bmj.325.7374.1195 DOI: https://doi.org/10.1136/bmj.325.7374.1195
Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med 2003; 33: 23-32. https://doi.org/10.1017/S0033291702006384 DOI: https://doi.org/10.1017/S0033291702006384
Thornicroft G. Cannabis and psychosis. Is there epidemiological evidence for an association? Br J Psychiatry 1990; 157: 25-33. https://doi.org/10.1192/bjp.157.1.25 DOI: https://doi.org/10.1192/bjp.157.1.25
Linzen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent‐onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273-9. https://doi.org/10.1001/archpsyc.1994.03950040017002 DOI: https://doi.org/10.1001/archpsyc.1994.03950040017002
Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992; 85: 127-30. https://doi.org/10.1111/j.1600-0447.1992.tb01456.x DOI: https://doi.org/10.1111/j.1600-0447.1992.tb01456.x
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM‐IV. 4th ed. Washington (DC): American Psychiatric Association; 1994.
Sharma P, Murthy P, Bharath MM. Chemistry, metabolism and toxicology of cannabis: Clinical implications. Iran J Psychiatry 2012; 7: 149-156.
Gold MS, Miller NS. Seeking drugs/alcohol and avoiding withdrawal: the neuroanatomy of drive states and withdrawal. Psychiatr Ann 1992; 22(8): 430-5. https://doi.org/10.3928/0048-5713-19920801-09 DOI: https://doi.org/10.3928/0048-5713-19920801-09
Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 2007; 32: 607-615. https://doi.org/10.1038/sj.npp.1301127 DOI: https://doi.org/10.1038/sj.npp.1301127
Nocon A, Wittchen HU, Pfister H, Zimmermann P, Lieb R. Dependence symptoms in young cannabis users? A prospective epidemiological study. J Psychiatr Res 2006; 40: 394-403. https://doi.org/10.1016/j.jpsychires.2005.07.011 DOI: https://doi.org/10.1016/j.jpsychires.2005.07.011
Lamarine RJ. Marijuana: Modern medical chimaera. J Drug Educ 2012; 42: 1-11. https://doi.org/10.2190/DE.42.1.a DOI: https://doi.org/10.2190/DE.42.1.a
Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007; 4: 1770-1804. https://doi.org/10.1002/cbdv.200790152 DOI: https://doi.org/10.1002/cbdv.200790152
Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, McGrath J et al. The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study. Brody JP, ed. PLoS One. 2013;8(10):e76635. DOI: https://doi.org/10.1371/journal.pone.0076635
David Levinson. Encyclopedia of Crime and Punishment. SAGE Publications. 2002, 572. DOI: https://doi.org/10.4135/9781412950664
Wikipedia. Cannabis (drug). [cited 2018 February 12]: Available from: http://enacademic.com/dic.nsf/enwiki/727377/ Cannabis_%28drug%29
EMCDDA. Cannabis reader: Global issues and local experiences, Perspectives on Cannabis controversies, treatment and regulation in Europe, 2008; 157. [cited 2018 February 12]: Available from: http://www.emcdda.europa.eu/ publications/monographs/cannabis_en
Frank VA. Danish drug policy-Shifting from liberalism to repression. Drugs and Alcohol Today 2008; 8(2): 26-33. https://doi.org/10.1108/17459265200800015 DOI: https://doi.org/10.1108/17459265200800015
Myers LL. Marijuana goes legal in Washington state amid mixed messages. [cited 2018 February 12]: Available from: https://www.reuters.com/article/us-usa-marijuana-washington/marijuana-goes-legal-in-washington-state-amid-mixed-messages-idUSBRE8B506L20121206
Vicky Baker. "Marijuana laws around the world: what you need to know". [cited 2018 February 12]: Available from: https://www.theguardian.com/travel/2013/dec/11/uruguay-marijuana-laws-around-world
Rojo M. Uruguay pharmacies start selling cannabis straight to consumers. [cited 2018 February 12]: Available from: https://www.theguardian.com/world/2017/jul/19/uruguay-marijuana-sale-pharmacies
Abraham B. Uttarakhand To Become First Indian State To Legalise Cannabis Cultivation. [cited 2018 February 12]: Available from: https://www.indiatimes.com/news/india/ uttarakhand-to-become-first-indian-state-to-legalise-cannabis-cultivation-247769.html
Alchimia Grow Shop'sofficial blog. Medical marijuana news, December 2015, Australia will allow to grow cannabis for medical studies. [cited 2018 February 12]: Available from: https://www.alchimiaweb.com/blogen/medical-marijuana-news-december-2015/
Kane L. Canadians facing pot charges in limbo, while Liberals work on legalization. [cited 2018 February 12]: Available from: https://www.theglobeandmail.com/news/ british-columbia/canadians-facing-pot-charges-in-limbo-while-liberals-work-on-legalization/article27935465/
Anonymous. Drug Policy of the Czech Republic. [cited 2018 February 12]: Available from: http://www.popflock.com/learn? s= Drug_policy_of_the_Czech_Republic
Castaneda JG. The summit of muted intentions. [cited 2018 February 12]: Available from: http://www.aljazeera.com/ indepth/opinion/2012/03/2012327125714281880.html
Anonymous. Ecuador: Aprueban tenencia de drogas para consume. [cited 2018 February 12]: Available from: https://www.revolvy.com/main/index.php?s=El%20Comercio%20(Ecuador)
Jorge HT, and Angles ZC. Mexico: The Law Against Small-Scale Drug Dealing. A Doubtful Venture, Series on Legislative Reform of Drug Policies. Legislative, Nr 3, 2009.
European Monitoring Centre for Drugs and Drug Addiction. Drug policy profiles — Portugal. [cited 2018 February 12]: Available from: http://www.emcdda.europa.eu/publications/ drug-policy-profiles/portugal_en
Anonymous. Marijuana. [cited 2018 February 12]: Available from: http://www.popflock.com/learn?s=Marijuana
Motel S. 6 facts about marijuana. [cited 2018 February 12]: Available from: http://www.pewresearch.org/fact-tank/2015/ 04/14/6-facts-about-marijuana/
Wadley J. Daily marijuana use among college students highest since 1980. [cited 2018 February 12]: Available from: http://ns.umich.edu/new/releases/23088-daily-marijuana-use-among-u-s-college-students-highest-since-1980
McCarthy J. More Than Four in 10 Americans Say They Have Tried Marijuana. Available from: http://news.gallup. com/poll/184298/four-americans-say-tried-marijuana.aspx. Accessed on 16 February 2018.
Jonathan PC, Angela H, Beau K, Mark ARK. Marijuana Legalization: What Everyone Needs to Know. [cited 2018 February 12]: Available from: https://global.oup.com/ academic/product/marijuana-legalization-9780199913718?cc=us&lang=en
Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013; 33(2): 195-209. https://doi.org/10.1002/phar.1187 DOI: https://doi.org/10.1002/phar.1187
Scientific American. Panel recommends FDA approval of epilepsy drug derived from marijuana [cited 2018 April 23]: Available from: https://www.scientificamerican.com/article/ panel-recommends-fda-approval-of-epilepsy-drug-derived-from-marijuana/?sf187440701=1